Skip to content
10-K

Annual Report

TG THERAPEUTICS, INC. TGTX

0001437749-26-006133

← back to feed
Filed
Feb 27, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 25, 2026 159.69M sh
Shares Diluted FY 2025 · Dec 31, 2025 161.41M sh
Shares Diluted FY 2025 · Dec 31, 2024 160.34M sh
Shares Diluted FY 2025 · Dec 31, 2023 148.51M sh
Capex FY 2025 · Dec 31, 2025 $214K
Capex FY 2025 · Dec 31, 2024 $45K
Capex FY 2025 · Dec 31, 2023 $0
Operating Cash Flow FY 2025 · Dec 31, 2025 −$24.77M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$40.52M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$31.41M
Long Term Debt FY 2025 · Dec 31, 2025 $245.65M
Long Term Debt FY 2025 · Dec 31, 2024 $244.43M
Short Term Investments FY 2025 · Dec 31, 2025 $62.82M
Short Term Investments FY 2025 · Dec 31, 2024 $131.11M
Cash And Equivalents FY 2025 · Dec 31, 2025 $79.15M
Cash And Equivalents FY 2025 · Dec 31, 2024 $179.89M
Cash And Equivalents FY 2025 · Dec 31, 2023 $92.93M
Stockholders Equity FY 2025 · Dec 31, 2025 $648.02M
Stockholders Equity FY 2025 · Dec 31, 2024 $222.36M
Stockholders Equity FY 2025 · Dec 31, 2023 $160.5M
Stockholders Equity FY 2025 · Dec 31, 2022 $58.59M
Current Liabilities FY 2025 · Dec 31, 2025 $153.76M
Current Liabilities FY 2025 · Dec 31, 2024 $90.68M
Total Liabilities FY 2025 · Dec 31, 2025 $415.23M
Total Liabilities FY 2025 · Dec 31, 2024 $355.33M
Current Assets FY 2025 · Dec 31, 2025 $630.76M
Current Assets FY 2025 · Dec 31, 2024 $566.36M
Total Assets FY 2025 · Dec 31, 2025 $1.06B
Total Assets FY 2025 · Dec 31, 2024 $577.69M
Eps Diluted FY 2025 · Dec 31, 2025 $2.77
Eps Diluted FY 2025 · Dec 31, 2024 $0.15
Eps Diluted FY 2025 · Dec 31, 2023 $0.09
Eps Basic FY 2025 · Dec 31, 2025 $3.10
Eps Basic FY 2025 · Dec 31, 2024 $0.16
Eps Basic FY 2025 · Dec 31, 2023 $0.09
Sga Expense FY 2025 · Dec 31, 2025 $232.03M
Sga Expense FY 2025 · Dec 31, 2024 $154.3M
Sga Expense FY 2025 · Dec 31, 2023 $122.71M
Rd Expense FY 2025 · Dec 31, 2025 $160.22M
Rd Expense FY 2025 · Dec 31, 2024 $94.29M
Rd Expense FY 2025 · Dec 31, 2023 $76.19M
Net Income FY 2025 · Dec 31, 2025 $447.18M
Net Income FY 2025 · Dec 31, 2024 $23.38M
Net Income FY 2025 · Dec 31, 2023 $12.67M
Operating Income FY 2025 · Dec 31, 2025 $123.32M
Operating Income FY 2025 · Dec 31, 2024 $41.93M
Operating Income FY 2025 · Dec 31, 2023 $20.63M
Revenue FY 2025 · Dec 31, 2025 $616.29M
Revenue FY 2025 · Dec 31, 2024 $329M
Revenue FY 2025 · Dec 31, 2023 $233.66M